Evidence map›Paper›PMID 22558053›Full record

ArticleGMS current topics in otorhinolaryngology, head and neck surgery2011

Paragangliomas and paraganglioma syndromes.

Carsten Christof Boedeker

Open access · greenAbstract read
In one paragraph

Article in GMS current topics in otorhinolaryngology, head and neck surgery, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 63 citations in OpenAlex.

  1. Immunohistochemistry and Mutation Analysis ofInternational journal of molecular sciences · 2020
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Midline mandibulotomy for large carotid body tumors: a valuable approach.Journal of vascular surgery cases and innovative techniques · 2023
    Article
  8. Somatic Mutation Profiling in Head and Neck Paragangliomas.The Journal of clinical endocrinology and metabolism · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Jugular foramen paragangliomas: preoperative transcatheter particle embolization.Journal of cerebrovascular and endovascular neurosurgery · 2020
    Article
  13. Head and Neck Paragangliomas-A Genetic Overview.International journal of molecular sciences · 2020
    Review
  14. Article
  15. Evolving management strategies in head and neck paragangliomas: A single-centre experience with 147 patients over a 60-year period.Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery · 2019
    Article
  16. Mathematical Models for Tumor Growth and the Reduction of Overtreatment.Journal of neurological surgery. Part B, Skull base · 2019
    Article
  17. Article
  18. Bilateral carotid body tumor resection in a female patient.International journal of surgery case reports · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Carsten Christof BoedekerDepartment of Otorhinolaryngology, Head and Neck Surgery, University of Freiburg, Germany.
Universitätsklinik für Hals-, Nasen- und Ohrenheilkunde · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paragangliomas are rare tumors of neural crest origin. They are benign in the majority of cases and are characterized by a strong vascularisation.In the head and neck region they most commonly occur as carotid body tumors. Jugulotympanic and especially vagal paragangliomas are seen less frequently. Complete surgical resection represents the only curative treatment option even though resection of locally advanced tumors regularly results in lesions of the lower cranial nerves and major vessels. Appoximately 30% of all head and neck paragangliomas (HNPs) are hereditary and associated with different tumor syndromes. The paraganglioma syndromes 1, 3 and 4 (PGL 1, 3 and 4) make up the majority of those familial cases. PGL 1 is associated with mutations of the succinate dehydrogenase subunit D (SDHD) gene, PGL 3 is caused by SDHC and PGL 4 by SDHB gene mutations. Multiple HNPs and the occurance of HNPs together with pheochromocytomas are seen in SDHD as well as SDHB mutation carriers. In patients with SDHB mutations the risk for the development of malignant paraganglial tumors is significantly higher compared to SDHC and SDHD patients as well as patients with sporadic tumors. SDHC mutation carriers almost exclusively present with benign HNP that are unifocal in the majority of cases. The role of transmission is autosomal dominant for all three symptoms. Interestingly, there is a "parent-of-origin-dependent-inheritance" in subjects with SDHD gene mutations. This means that the disease phenotype may only become present if the mutation is inherited through the paternal line. We recommend screening for mutations of the genes SDHB, SDHC and SDHD in patients with HNPs. Certain clinical parameters can help to set up the order in which the three genes should be tested.

Indexed as

glomus tumorparagangliomaparaganglioma syndromepheochromocytomarare diseases

Identifiers

PMID22558053
PMCPMC3341580
OpenAlexW1592313203

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.